Simultaneous identification of various antinuclear antibodies using an automated multiparameter line immunoassay system

Lupus

Volumn 12, Issue 8, 2003, Pages 623-629

  Lopez Longo F J ^a   Rodriguez Mahou M ^a   Escalona Monge, M ^a   Gonzalez C M ^a   Monteagudo, I ^a   Carreno Perez L ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Anti Jo 1; Anti Ro SS A; Anti Ro SS B; Anti Scl 70; Anti Sm; Anti U1RNP; Antiribonucleoproteins; Autoantibodies; Systemic lupus erythematosus

Indexed keywords

ANTINUCLEAR ANTIBODY; CENTROMERE ANTIBODY; HISTONE ANTIBODY; JO 1 ANTIBODY; LA ANTIBODY; RIBONUCLEOPROTEIN ANTIBODY; RO ANTIBODY; SCL 70 ANTIBODY; SM ANTIBODY; UNCLASSIFIED DRUG;

ACCURACY; ANIMAL TISSUE; ANTIBODY DETECTION; ARTICLE; AUTOMATION; COUNTER IMMUNOELECTROPHORESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; RABBIT; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIBODIES, ANTINUCLEAR; AUTOMATIC DATA PROCESSING; BIOLOGICAL MARKERS; COUNTERIMMUNOELECTROPHORESIS; FALSE POSITIVE REACTIONS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOASSAY; LUPUS ERYTHEMATOSUS, SYSTEMIC; POLYMYOSITIS; PREDICTIVE VALUE OF TESTS; RIBONUCLEOPROTEIN, U1 SMALL NUCLEAR; SCLERODERMA, SYSTEMIC; SENSITIVITY AND SPECIFICITY;

EID: 0042967596     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203303lu439oa     Document Type: Article

References (43)

1. Tan EM, Feltkamp TEW, Smolen JS et al. Range of antinuclear antibodies in 'healthy' individuals. Arthritis Rheum 1997; 40: 1601-1611.
2. López-Longo FJ. Antinuclear antibodies. Rev Esp Reumatol 1996; 23: 341-395.
3. Elkon KB, Jankowsky PW. Fine specificities of autoantibodies directed against the Ro, La, Sm, RNP and Jo-1 proteins defined by two-dimensional gel electrophoresis and immunoblotting. J Immunol 1985; 134: 3819-3824.
4. Maddison PJ, Skinner RP, Vlachojiannopoulos P, Brennand DM, Hough D. Antibodies to nRNP, Sm, o (SSA) and La (SSB) detected by ELISA: their specificity and interrelations in connective tissue disease sera. Clin Exp Immunol 1985; 62: 337-345.
5. Van Venrooij WJ, Charles P, Maini RN. The consensus workshops for the detection of autoantibodies to intracellular antigens in rheumatic diseases. J Immunol Methods 1991; 140: 181-189.
6. López-Longo FJ, González CM, Rodríguez-Mahou M et al. Clinical expression of systemic lupus erythematosus with anti-U1RNP and anti-Sm antibodies. Rev Clín Esp 1997; 197: 329-335.
7. López-Longo FJ, Monteagudo I, Rodríguez-Mahou M et al. Discrepancies between counterimmunoelectrophoresis, immunoblotting and ELISA in the detection of anti-U1RNP and anti-Sm antibodies. Boletin CIAR 1995; V: 7-13.
8. López-Longo FJ, Rodríguez-Mahou M, Escalona M et al. Heterogeneity of the anti-Ro(SS-A) response in rheumatic diseases. J Rheumatol 1994; 21: 1450-1456.
9. Provost TT, Levin LS, Watson RM, Mayo M, Ratrie H. Detection of anti-Ro (SS-A) antibodies by gel double diffusion and a 'sandwich' ELISA in systemic and subacute cutaneous lupus erythematosus and Sjögren's syndrome. J Autoimmun 1991; 4: 87-96.
10. Gordon T, Mavrangelos C, McCluskey J. Restricted epitope recognition by preciptin-negative anti-La/SS-B positive sera. Arthritis Rheum 1992; 35: 663-666.
11. Ter Borg EJ, Groen H, Horts G, Limburg PC, Wonda AA, Kallemberg CGM. Clinical associations of antiribonucleoprotein antibodies in patients with systemic lupus erythematosus. Semin Arthritis Rheum 1990; 20: 164-173.
12. Hines JJ, Danho W, Elkon KB. Detection and quantitation of human anti-Sm antibodies using synthetic peptides and recombinant Sm B antigens. Arthritis Rheum 1991; 34: 572-579.
13. Pettersson I, Wang G, Smitz EI et al. The use of immunoblotting and immunoprecipitation of (U) snRNP in the analysis of sera of patients with mixed connective tissue disease and systemic lupus erythematosus. A cross-sectional longitudinal study. Arthritis Rheum 1986; 29: 986-996.
14. De Rooij DJ, Van De Putte LB, Habets WJ, Verbee KAL, Van Venrooij WJ. The use of immunoblotting to detect antibodies to nuclear and cytoplasmatic antigens. Scand J Rheumatol 1988; 17: 353-364.
15. Kallenberg CGM, Ter Borg EJ, Jaarsma D, Limburg PC. Detection of autoantibodies to ribonucleoproteins by counterimmnunoelectrophoresis, immunoblotting and RNA-immunoprecipitation: comparison of results. Clin Exp Rheumatol 1990; 8: 35-40.
16. Whittingham S. SLE or MCTD and the snurps in the splicing. J Rheumatol 1990; 17: 1260-1262.
17. Rothfield N, Whitaker D, Bordwell B, Wiener E, Senecal JL, Eamshaw W. Detection of anticentromere antibodies using cloned autoantigen CENP-B. Arthritis Rheum 1987; 30: 1416-1419.
18. Boire G, López-Longo FJ, Lapointe S, Ménard HA. Sera from patients with autoimmune disease recognize conformational determinants on the 60 kD Ro/SS-A protein. Arthritis Rheum 1991; 34: 722-730.
19. López-Longo FJ, Gonzlez CM, Monteagudo I et al. Simultaneous detection of different antinuclear antibodies using an automatic multiparameter line immunoassay system. EULAR Annual European Congress of Rheumatology, June 21-24, Nice 2000 (abstract POS-644). Ann Rheum Dis 2000; 59 (suppl 1): 213.
20. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
21. Masi AT, Rodnan GP, Medsger TA et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-590.
22. Alarcón-Segovia D, Cardiel MM. Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients. J Rheumatol 1989; 16: 328-334.
23. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med 1975; 292: 344-347, 403-406.
24. Kurata N, Tan EM. Identification of antibodies to nuclear acidic antigens by counterimmunoelectrophoresis. Arthritis Rheum 1976; 19: 574-580.
25. López-Longo FJ, Fernández J, Monteagudo I et al. Clinical and serologic evolution of patients with mixed connective tissue disease. Rev Clin Esp 1994; 194: 682-688.
26. Rodríguez-Mahou M, López-Longo FJ, Grau R, Gurbindo D, Carreño L, Fernández-Cruz E. Autoimmune phenomena in children with human immunodeficiency virus infection and acquired immunodeficiency syndrome. Acta Pediatrica 1994; Suppl 400: 31-34.
27. López-Longo FJ, Rodríguez-Mahou M et al. Detection of anti-RNP and anti-Sm antibodies by immunoblotting and counterimmunoelectrophoresis using the same rabbit thymus extract. Rev Esp Reumatol 1994; 20: 6-12.
28. Clark GM, Reichlin M, Tomasi TB. Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythematosus. J Immunol 1969; 102: 117-122.
29. López-Longo FJ, Monteagudo I, González CM, Grau R, Carreño L. Systemic lupus erythematosus: clinical expression and anti-Ro/SS-A response in patients with and without lesions of subacute cutaneous lupus erythematosus. Lupus 1997; 6: 32-39.
30. López-Longo FJ, Monteagudo I, González CM et al. Anti-BB′-Sm antibodies, anticardiolipin antibodies and thrombosis in systemic lupus erythematosus. J Rheumatol 1998; 25: 1743-1749.
31. González CM, López-Longo FJ, Samson J et al. Antiribonucleoprotein antibodies in children with human immunodeficiency virus infection. A comparative study with childhood-onset systemic lupus erythematosus. AIDS Patient Care and STDs 1998; 12: 21-28.
32. Rutjes SA, Vree-Egberts WT, Jongen P, Van Den Hoogen F, Pruijn GJ, Van Venrooij WJ. Anti-Ro52 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy. Clin Exp Immunol 1997; 109: 32-40.
33. Galen RS, Gambino SR (eds). Beyond mortality. The predictive value and efficiences of medical diagnosis. John Wiley and Sons: New York, 1975, 10-14.
34. Meheus L, Van Venrooij WJ, Wiik A et al. Multicenter validation of recombinant, natural and synthetic antigens used in a single multiparameter assay for the detection of specific antinuclear antibodies in connective tissue disorders. Clin Exp Rheumatol 1999; 17: 205-214.
35. Frank MB, McCubbin V, Trieu E, Wu Y, Isenberg DA, Targoff IN. The association of anti-Ro-52 autoantibodies with myositis and scleroderma autoantibodies. J Autoimmun 1999; 12: 137-142.
36. St-Clair EW, Pisetsky DS, Reich CF, Chambers JC, Keene JD. Quantitative immunoassay of anti-La antibodies using purified recombinant La antigen. Arthritis Rheum 1988; 31: 506-514.
37. Williams G, Stocks MR, Charles PJ, Maini RN. Antibodies to La, Jo-1, nRNP and Sm detected by multitrack immunoblotting using a novel filter holder: a comparative study with counterimmunoelectrophoresis and immunodiffusion using sera from patients with systemic lupus erythematosus and Sjögren's syndrome. J Immunol Methods 1986; 91: 65-73.
38. McCauliffe DP, Yin H, Wang LX, Lucas L. Autoimmune sera react with multipe epitopes on recombinant 52 and 60 kDa Ro(SS-A) proteins. J Rheumatol 1994; 21: 1073-1080.
39. Beer RG, Rischmueller M, Coates T et al. Nonprecipitating anti-La (SS-B) autoantibodies in primary Sjögren's syndrome. Clin Immunol Immunopathol 1996; 79: 314-318.
40. Zimmermann C, Smolen JS, Graninger W et al. Fine specificity of anti-Ro (SSA) autoantibodies and clinical manifestations in patients with systemic lupus erythematosus. J Rheumatol 1996; 23: 1897-1903.
41. Bozic B, Pruijn GJ, Rozman B, Van Venrooij WJ. Sera from patients with rheumatic disease recognize different epitope regions on the 52 kD Ro/ SS-A protein. Clin Exp Immunol 1993; 94: 227-235.
42. Frank MB, Itoh K, McCubbin V. Epitope mapping of the 52-kD Ro/SSA autoantigen. Clin Exp Immunol 1994; 95: 390-396.
43. Van Dam AP, Van Den Brink HG, Smeenk RJT. Technical problems concerning the use of immunoblots for the detection of ANA. J Immunol Methods 1990; 129: 63-70.